Question 1

Who are the top researchers at Pharmaq (Norway)?

Accepted Answer

Ranked on the quality score, Kjersti Gravningen lead among researchers whose main affiliation is Pharmaq (Norway).

Question 2

What are the most cited papers from Pharmaq (Norway)?

Accepted Answer

The most cited paper from Pharmaq (Norway) is "Status and future perspectives of vaccines for industrialised fin-fish farming" (Bjørn Erik Brudeseth, Rune Wiulsrød, Børge Nilsen Fredriksen et al., 2013), with 303 citations. Next come "Cardiomyopathy Syndrome of Atlantic Salmon (Salmo salar L.) Is Caused by a Double-Stranded RNA Virus of the Totiviridae Family" (193) and "Disturbance of the intestinal mucosal immune system of farmed Atlantic salmon (Salmo salar), in response to long-term hypoxic conditions" (156).

Question 3

Which research topics does Pharmaq (Norway) publish most on?

Accepted Answer

By volume in 2022-now: Aquaculture disease management and microbiota, Aquaculture Nutrition and Growth, Myxozoan Parasites in Aquatic Species and Fish Ecology and Management Studies.

Question 4

Which keywords describe research at Pharmaq (Norway)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Aquaculture, Antibiotic Resistance, Innate Immunity, Cytokines, Viral Diseases, Fish Immunology, Probiotics and Epidemiology.

Question 5

Which fields of science does Pharmaq (Norway) work in?

Accepted Answer

In all years, 65% of research at Pharmaq (Norway) is in Life Sciences, 21% in Physical Sciences. Its largest fields are Immunology and Microbiology (30%), Biochemistry, Genetics and Molecular Biology (20%), Environmental Science (15%). It does 3.5× the world's share of Life Sciences.

Question 6

Is Pharmaq (Norway)'s research output growing?

Accepted Answer

Output in 2022-2025 was 16% higher than in 2018-2021.